<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font26">and </span>
   <span class="font18">vaccine </span>
   <span class="font15">vaccines </span>
   <span class="font14">for </span>
   <span class="font13">coronavirus </span>
   <span class="font13">with </span>
   <span class="font13">[]. </span>
   <span class="font13">are </span>
   <span class="font12">The </span>
   <span class="font12">immune </span>
   <span class="font12">protein </span>
   <span class="font12">cells </span>
   <span class="font12">have </span>
   <span class="font12">respiratory </span>
   <span class="font12">virus </span>
   <span class="font12">that </span>
   <span class="font12">VLPs </span>
   <span class="font12">against </span>
   <span class="font12">syndrome </span>
   <span class="font12">{background </span>
   <span class="font11">from </span>
   <span class="font11">SARS-CoV- </span>
   <span class="font11">viral </span>
   <span class="font11">development </span>
   <span class="font11">clinical </span>
   <span class="font11">margin </span>
   <span class="font11">particles </span>
   <span class="font11">VLP </span>
   <span class="font11">immunity </span>
   <span class="font11">severe </span>
   <span class="font11">virus-like </span>
   <span class="font11">{border-style </span>
   <span class="font11">has </span>
   <span class="font11">proteins </span>
   <span class="font11">responses </span>
   <span class="font11">cell </span>
   <span class="font11">px;} </span>
   <span class="font11">response </span>
   <span class="font11">spike </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">acute </span>
   <span class="font11">mRNA </span>
   <span class="font11">recombinant </span>
   <span class="font11">DNA </span>
   <span class="font11">Immunol </span>
   <span class="font11">antigenic </span>
   <span class="font11">can </span>
   <span class="font11">into </span>
   <span class="font11">vector </span>
   <span class="font11">antibodies </span>
   <span class="font11">human </span>
   <span class="font11">induce </span>
   <span class="font11">production </span>
   <span class="font10">East </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">been </span>
   <span class="font10">biomimetic </span>
   <span class="font10">humoral </span>
   <span class="font10">through </span>
   <span class="font10">vaccines, </span>
   <span class="font10">Middle </span>
   <span class="font10">Virol </span>
   <span class="font10">adenovirus </span>
   <span class="font10">antigen </span>
   <span class="font10">cellular </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">may </span>
   <span class="font10">mice </span>
   <span class="font10">neutralizing </span>
   <span class="font10">used </span>
   <span class="font10">vectors </span>
   <span class="font10">nanoparticles </span>
   <span class="font10">platform </span>
   <span class="font10">vaccines. </span>
   <span class="font10">COVID- </span>
   <span class="font10">inactivated </span>
   <span class="font10">including </span>
   <span class="font10">novel </span>
   <span class="font10">protective </span>
   <span class="font10">type </span>
   <span class="font10">was </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">its </span>
   <span class="font10">nanoparticle </span>
   <span class="font10">potential </span>
   <span class="font10">which </span>
   <span class="font10">SARS </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">acid </span>
   <span class="font10">antigens </span>
   <span class="font10">based </span>
   <span class="font10">design </span>
   <span class="font10">expression </span>
   <span class="font10">influenza </span>
   <span class="font10">particle </span>
   <span class="font10">technology </span>
   <span class="font10">these </span>
   <span class="font10">this </span>
   <span class="font10">Biotechnol </span>
   <span class="font10">Phase </span>
   <span class="font10">Res </span>
   <span class="font10">Rev </span>
   <span class="font10">also </span>
   <span class="font10">both </span>
   <span class="font10">candidate </span>
   <span class="font10">cells. </span>
   <span class="font10">conventional </span>
   <span class="font10">disease </span>
   <span class="font10">effective </span>
   <span class="font10">immunization </span>
   <span class="font10">induces </span>
   <span class="font10">infectious </span>
   <span class="font10">produced </span>
   <span class="font10">purification </span>
   <span class="font10">px; </span>
   <span class="font10">rapid </span>
   <span class="font10">research </span>
   <span class="font10">such </span>
   <span class="font10">systemic </span>
   <span class="font10">{font-family </span>
   <span class="font10">Biomimetic </span>
   <span class="font10">China </span>
   <span class="font10">CpG </span>
   <span class="font10">However, </span>
   <span class="font10">activation </span>
   <span class="font10">adjuvants </span>
   <span class="font10">antibody </span>
   <span class="font10">binding </span>
   <span class="font10">delivery </span>
   <span class="font10">domain </span>
   <span class="font10">font-size </span>
   <span class="font10">future </span>
   <span class="font10">infection </span>
   <span class="font10">membrane </span>
   <span class="font10">more </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">protection </span>
   <span class="font10">strategy </span>
   <span class="font10">strong </span>
   <span class="font10">structure </span>
   <span class="font10">studies </span>
   <span class="font10">subunit </span>
   <span class="font10">surface </span>
   <span class="font10">taken </span>
   <span class="font10">using </span>
   <span class="font10">vaccine. </span>
   <span class="font10">Available </span>
   <span class="font10">Drug </span>
   <span class="font10">RNA </span>
   <span class="font10">VLP-based </span>
   <span class="font10">When </span>
   <span class="font10">Wuhan </span>
   <span class="font10">adjuvant </span>
   <span class="font10">capable </span>
   <span class="font10">cells, </span>
   <span class="font10">double; </span>
   <span class="font10">elicits </span>
   <span class="font10">epitopes </span>
   <span class="font10">first </span>
   <span class="font10">high </span>
   <span class="font10">highly </span>
   <span class="font10">induced </span>
   <span class="font10">infected </span>
   <span class="font10">levels </span>
   <span class="font10">live-attenuated </span>
   <span class="font10">memory </span>
   <span class="font10">methods </span>
   <span class="font10">molecules </span>
   <span class="font10">nanotechnology </span>
   <span class="font10">new </span>
   <span class="font10">nucleic </span>
   <span class="font10">receptor </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">responses. </span>
   <span class="font10">serotype </span>
   <span class="font10">specific </span>
   <span class="font10">viruses </span>
   <span class="font10">vivo </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Elsevier </span>
   <span class="font10">HPV </span>
   <span class="font10">Live-attenuated </span>
   <span class="font10">Med </span>
   <span class="font10">Therefore, </span>
   <span class="font10">activate </span>
   <span class="font10">advances </span>
   <span class="font10">antiviral </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">developing </span>
   <span class="font10">development. </span>
   <span class="font10">efficacy </span>
   <span class="font10">enhance </span>
   <span class="font10">host </span>
   <span class="font10">immunogenic </span>
   <span class="font10">lethal </span>
   <span class="font10">long-term </span>
   <span class="font10">outbreak </span>
   <span class="font10">peptides </span>
   <span class="font10">peptides. </span>
   <span class="font10">phase </span>
   <span class="font10">produce </span>
   <span class="font10">protects </span>
   <span class="font10">proteins, </span>
   <span class="font10">provide </span>
   <span class="font10">reactions </span>
   <span class="font10">reported </span>
   <span class="font10">solid; </span>
   <span class="font10">than </span>
   <span class="font10">then </span>
   <span class="font10">therapeutic </span>
   <span class="font10">traditional </span>
   <span class="font10">trialLancet </span>
   <span class="font10">vaccination </span>
   <span class="font10">vaccine: </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Fig. </span>
   <span class="font10">(SARS-CoV) </span>
   <span class="font10">APCs </span>
   <span class="font10">Discov </span>
   <span class="font10">Health </span>
   <span class="font10">Inactivated </span>
   <span class="font10">Inc. </span>
   <span class="font10">Induces </span>
   <span class="font10">MERS </span>
   <span class="font10">Nucleic </span>
   <span class="font10">Pharm </span>
   <span class="font10">Sci </span>
   <span class="font10">T-cell </span>
   <span class="font10">antibodies, </span>
   <span class="font10">approved </span>
   <span class="font10">available </span>
   <span class="font10">basis </span>
   <span class="font10">bold </span>
   <span class="font10">candidates </span>
   <span class="font10">centre </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">dendritic </span>
   <span class="font10">different </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">encoding </span>
   <span class="font10">engineering </span>
   <span class="font10">enhanced </span>
   <span class="font10">express </span>
   <span class="font10">free </span>
   <span class="font10">generated </span>
   <span class="font10">genetic </span>
   <span class="font10">good </span>
   <span class="font10">healthy </span>
   <span class="font10">homologous </span>
   <span class="font10">increase </span>
   <span class="font10">inducing </span>
   <span class="font10">induction </span>
   <span class="font10">innate </span>
   <span class="font10">large </span>
   <span class="font10">live </span>
   <span class="font10">loaded </span>
   <span class="font10">maturation </span>
   <span class="font10">molecules, </span>
   <span class="font10">most </span>
   <span class="font10">need </span>
   <span class="font10">one </span>
   <span class="font10">other </span>
   <span class="font10">owing </span>
   <span class="font10">pandemic </span>
   <span class="font10">particles: </span>
   <span class="font10">pathway. </span>
   <span class="font10">patients </span>
   <span class="font10">pneumonia </span>
   <span class="font10">preparation </span>
   <span class="font10">present </span>
   <span class="font10">promising </span>
   <span class="font10">proteins. </span>
   <span class="font10">pt;} </span>
   <span class="font10">rare </span>
   <span class="font10">resource </span>
   <span class="font10">response. </span>
   <span class="font10">results </span>
   <span class="font10">risk </span>
   <span class="font10">robust </span>
   <span class="font10">shown </span>
   <span class="font10">significant </span>
   <span class="font10">still </span>
   <span class="font10">study </span>
   <span class="font10">synthetic </span>
   <span class="font10">target </span>
   <span class="font10">targeting </span>
   <span class="font10">their </span>
   <span class="font10">trials </span>
   <span class="font10">type- </span>
   <span class="font10">types </span>
   <span class="font10">use </span>
   <span class="font10">vaccinia </span>
   <span class="font10">virulence </span>
   <span class="font10">well </span>
   <span class="font10">were </span>
   <span class="font10">work </span>
  </p>
 </body>
</html>
